Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Compulsory licensing
The European Commission’s proposal for an EU wide compulsory licensing mechanism
Ellen 't Hoen
-
April 27, 2023
Updated TRIPS Flexibilities Database
Ellen 't Hoen
-
April 17, 2023
Right to breathe takes precedence over company profits: Families of cystic...
Kaitlin Mara
-
February 28, 2023
Wrapping up 2021 – some noteworthy medicines law and policy events
Ellen 't Hoen
-
December 24, 2021
BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery:...
Medicines Law & Policy
-
April 13, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Some Surprises in the European Commission’s New Intellectual Property Strategy
Ellen 't Hoen
-
December 2, 2020
TRIPS Council to discuss IP and the public interest in the...
Ellen 't Hoen
-
July 29, 2020
Remdesivir developed country price announced
Ellen 't Hoen
-
June 30, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
1
2
3
Page 1 of 3
This work is licensed under Creative Commons.